A Clinical Trial on the Use of Lidocaine Infusion During Surgery for Pediatric Upper Extremity Fractures and Its Impact on Total Perioperative Opioid Requirements

Exclusion Criteria

• •Children \< 3 years or \> 18 years
• •Patients with allergy to local anesthetics
• •Patients who are eligible for an receive a peripheral nerve block
• •Patients with multi-trauma or open fractures
• •Patients with previous history of seizure disorder
• •Patients with conduction abnormalities or cardiac arrhythmia requiring chronic treatment
• •Patients on strong CYP450 inhibitors (fluvoxamine, erythromycin, ciprofloxacin, rifampin, allopurinol, ketoconazole, itraconazole)
• •Patients with chronic kidney or liver dysfunction
• •Patients with planned use of continuous infusion pain medications (opioids, ketamine, alpha-2- agonists)
• •Patients with positive pregnancy test prior to surgery or nursing mothers
• •Patients who parents decline enrollment